Lymphoid blast crisis during interferon-α therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis

International Journal of Hematology

Volumn 72, Issue 4, 2000, Pages 474-476

  Goto, Hideko ^a   Tsurumi, Hisashi ^a   Hara, Takeshi ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Blast crisis; Chronic myelogenous leukemia; Interferon

Indexed keywords

ALPHA INTERFERON;

ARTICLE; BLAST CELL CRISIS; BONE MARROW CELL; CASE REPORT; CELL CLONE; CHEMICALLY INDUCED DISORDER; CHRONIC MYELOID LEUKEMIA; DRUG EFFECT; FATALITY; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY;

BLAST CRISIS; CLONE CELLS; FATAL OUTCOME; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MIDDLE AGED; MYELOID CELLS;

EID: 0034568632     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999;340: 1330-1340.
2. Athens JW. Chronic myeloid leukemia. In: Lee OR, Bithel TC, Foerster J, Athens FW, Lukens J, eds. Wintrobe's Clinical Hematology. Vol. 2, 9th ed. Philadelphia, PA: Lea & Febiger; 1993;1969-199S.
3. Talpaz M, McCredie KB, Mavligit GM, Gutterman JU. Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood. 1983;62:689-692.
4. Kantarjian HM, O'Brien S, Anderlini P, Talpaz M. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996;87:3069-3081.
5. Kaplan SS, Krause JR, Srodes CH. Leukemia with multiple phenotypic expressions. Am J Clin Pathol. 1984;82:232-235.
6. Janossy G, Woodruff RK, Paxton A, et al. Membrane marker and cell separation studies in Phi-positive leukemia. Blood. 1978;51:861-877.
7. Alimena G, Lazzarino M, Morra E, et al. Clinical and cytologic characteristics of blastic phase in Ph-positive chronic myeloid leukemia treated with α-interferon. Leukemia. 1996;10:615-618.
8. Ambrosetti A, Krampera M, Veneri D, et al. Early lymphoid biastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-α. Int J Clin Lab Res. 1994;24:58-59.
9. Talpaz M, Kantarjian HM, McCredie KB, Keating MJ, Trujillo J, Gutterman J. Critical investigation of human a interferon in chronic myelogenous leukemia. Blood. 1987;69:1280-1288.
10. Wang J, Lin Q, Langsten H, Cooper MD. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity. 1995;3:475-484.
11. - thymocytes. Immunology. 1997;90:543-549.